Anifrolumab Pregnancy Study
Recruiting now
Conditions studied: Systemic Lupus Erythematosus
In brief
This is a non-interventional multi-database post-authorisation study to assess pregnancy-related safety data from women with SLE exposed to Anifrolumab.
Key facts
- Study ID
- NCT07049653
- Run by
- AstraZeneca
- People needed
- 500
- Starts
- 2026-06-04
- Expected to finish
- 2030-12-10
- Last updated by the study team
- 2026-07-08
Who can join
Age: 18 and older, up to 130. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Research Site — Cary, North Carolina, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.